Roche’s experimental oral drug giredestrant improved disease-free survival after breast cancer surgery in an interim late-stage trial, the company said. A scheduled interim analysis found the...
Women’s heath firm Organon has agreed to divest its Jada postpartum uterine bleeding system to Laborie Medical Technologies in a deal worth up to US$465m, as...
North London NHS Foundation Trust has signed a new partnership with leading digital health company Psyomics to revolutionise how people across Barnet, Camden, Enfield, Haringey, Islington...
A global survey is underway to rename polycystic ovary syndrome (PCOS) to better reflect the condition and its impact on millions of women worldwide. PCOS can...
Pregnancy may significantly increase the risk of brain ruptures in women with arteriovenous malformations, according to findings presented at a major neurosurgery meeting. The condition involves...
A woman has accused the government of “dragging its feet” over reforms for women harmed by pelvic mesh implants, five years after a landmark report. Campaigners...
Children born by planned caesarean section may face a 21 per cent higher risk of developing acute lymphoblastic leukaemia (ALL) later in life, new research has...
A groundbreaking, cross-industry initiative designed to improve adherence to clinical guidelines in the treatment of early and metastatic breast cancer has been launched by health data company Novellia....
A new daily pill for endometriosis has been approved for use on the NHS and could help over a thousand women in England every year manage...
Morgan Rose, Chief Science Officer at Ema
